Marko Barešić

501 total citations
24 papers, 114 citations indexed

About

Marko Barešić is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, Marko Barešić has authored 24 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 8 papers in Rheumatology. Recurrent topics in Marko Barešić's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Systemic Sclerosis and Related Diseases (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Marko Barešić is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Systemic Sclerosis and Related Diseases (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Marko Barešić collaborates with scholars based in Croatia. Marko Barešić's co-authors include Branimir Anić, Miroslav Mayer, Nada Čikeš, Ana Hečimović, Vladimir Gašparović, Kamelija Žarković, Radovan Radonić, Luka Brčić, Katherina Bernadette Sreter and Ivan Gornik and has published in prestigious journals such as Lupus, Clinical Rheumatology and Biomedicines.

In The Last Decade

Marko Barešić

23 papers receiving 110 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Barešić Croatia 7 40 28 26 22 17 24 114
Manuel Salgado Portugal 7 9 0.2× 38 1.4× 19 0.7× 26 1.2× 25 1.5× 32 128
Stefania Barruscotti Italy 7 14 0.3× 16 0.6× 23 0.9× 7 0.3× 16 0.9× 28 113
Toby Coates Australia 6 12 0.3× 24 0.9× 10 0.4× 9 0.4× 15 0.9× 14 106
Olga Cerón United States 6 26 0.7× 46 1.6× 29 1.1× 16 0.7× 4 0.2× 6 285
Nicole Garcia United States 9 79 2.0× 15 0.5× 77 3.0× 12 0.5× 40 2.4× 26 220
Kurumi Asako Japan 7 35 0.9× 53 1.9× 39 1.5× 10 0.5× 24 1.4× 17 143
Sepideh Darougar Iran 6 21 0.5× 15 0.5× 15 0.6× 7 0.3× 21 1.2× 31 121
Jesus Loarce‐Martos Spain 4 15 0.4× 26 0.9× 50 1.9× 27 1.2× 14 0.8× 16 138
Maki Murata Japan 6 41 1.0× 13 0.5× 47 1.8× 24 1.1× 7 0.4× 13 163
Anthony J. Perri United States 7 25 0.6× 20 0.7× 39 1.5× 26 1.2× 54 3.2× 8 140

Countries citing papers authored by Marko Barešić

Since Specialization
Citations

This map shows the geographic impact of Marko Barešić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Barešić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Barešić more than expected).

Fields of papers citing papers by Marko Barešić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Barešić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Barešić. The network helps show where Marko Barešić may publish in the future.

Co-authorship network of co-authors of Marko Barešić

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Barešić. A scholar is included among the top collaborators of Marko Barešić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Barešić. Marko Barešić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayer, Miroslav, et al.. (2025). Demographics and clinical manifestations in patients with Behçet’s disease: a retrospective observational study from a non-endemic country. Rheumatology International. 45(5). 102–102. 1 indexed citations
2.
Barešić, Marko, et al.. (2024). Prolonged eosinophilia caused by Strongyloidiasis in a patient with rheumatoid arthritis treated with upadacitinib. Modern Rheumatology Case Reports. 9(1). 6–9.
3.
Barešić, Marko, et al.. (2023). Real world experience with nintedanib in connective tissue disease-related interstitial lung disease: a retrospective cohort study. Clinical Rheumatology. 42(10). 2897–2903. 3 indexed citations
4.
5.
Barešić, Marko, et al.. (2022). Successful IL-17A inhibitor cycling in psoriatic arthritis patient: a case report and a literature review. Rheumatology International. 42(2). 365–370. 2 indexed citations
6.
Barešić, Marko, et al.. (2021). Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review. Rheumatology International. 41(12). 2233–2239. 6 indexed citations
7.
Barešić, Marko, et al.. (2021). Misleading symptoms of hereditary angioedema type II mimicking familial mediterranean fever.. PubMed. 45(2). 143–146. 1 indexed citations
8.
9.
Barešić, Marko, et al.. (2018). Improvement of neurological and ocular symptoms of Behçet’s disease after the introduction of infliximab. Rheumatology International. 38(7). 1301–1306. 6 indexed citations
10.
Barešić, Marko, et al.. (2017). Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature.. PubMed. 40(2). 169–75. 8 indexed citations
11.
Barešić, Marko, et al.. (2016). Different Therapeutic Paths (Colchicine vs. Anakinra) in Two Patients With Schnitzler’s Syndrome. Archives of Rheumatology. 31(4). 377–380. 4 indexed citations
12.
Barešić, Marko, et al.. (2016). Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab. Reumatologia/Rheumatology. 54(6). 321–325. 9 indexed citations
13.
Barešić, Marko & Branimir Anić. (2015). [Capillaroscopy in rheumatological practice--one center experience].. PubMed. 136(1-2). 28–32. 2 indexed citations
14.
Barešić, Marko, et al.. (2015). Solitary pulmonary amyloidoma mimicking lung cancer on 18F-FDG PET-CT scan in systemic lupus erythematosus patient. Lupus. 24(14). 1546–1551. 9 indexed citations
15.
Barešić, Marko, et al.. (2014). Eosinophilia-myalgia syndrome induced by excessive L-tryptophan intake from cashew nuts. Open Medicine. 9(6). 796–801. 2 indexed citations
16.
Barešić, Marko, et al.. (2012). Fever of unknown origin: large vessel vasculitis diagnosed by PET/CT. Rheumatology International. 33(9). 2417–2421. 10 indexed citations
17.
Barešić, Marko, et al.. (2010). Rare zoonosis (hemotrophic mycoplasma infection) in a newly diagnosed systemic lupus erythematosus patient followed by a Nocardia asteroides pneumonia. The Brazilian Journal of Infectious Diseases. 14(1). 92–95. 8 indexed citations
18.
Barešić, Marko, et al.. (2010). Rare zoonosis (hemotrophic mycoplasma infection) in a newly diagnosed systemic lupus erythematosus patient followed by a Nocardia asteroides pneumonia. The Brazilian Journal of Infectious Diseases. 14(1). 92–95. 6 indexed citations
19.
Anić, Branimir, et al.. (2010). Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies (ANCA) skin vasculitis: the first case reported in Croatia.. PubMed. 18(2). 104–6. 3 indexed citations
20.
Barešić, Marko, et al.. (2009). Survival after Severe acute Chromic Acid Poisoning Complicated with Renal and Liver Failure. Internal Medicine. 48(9). 711–715. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Salgado Breakdown of academic impact, for papers by Stefania Barruscotti Breakdown of academic impact, for papers by Toby Coates Breakdown of academic impact, for papers by Olga Cerón Breakdown of academic impact, for papers by Nicole Garcia Breakdown of academic impact, for papers by Kurumi Asako Breakdown of academic impact, for papers by Sepideh Darougar Breakdown of academic impact, for papers by Jesus Loarce‐Martos Breakdown of academic impact, for papers by Maki Murata Breakdown of academic impact, for papers by Anthony J. Perri
Rankless by CCL
2026